An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome.
Levy T, Holder JL Jr, Horrigan JP, Snape MF, McMorn A, Layton C, Silver H, Friedman K, Grosman H, Underwood S, Halpern D, Zweifach J, Siper PM, Kolevzon A.
Levy T, et al. Among authors: grosman h.
HGG Adv. 2024 Dec 16:100393. doi: 10.1016/j.xhgg.2024.100393. Online ahead of print.
HGG Adv. 2024.
PMID: 39690738
Free article.